Document is current
Any future updates will be listed below
-
Authors
Margolin, Emily
Stern, Lily K.
Argiro, Alessia
Rosenthal, Julie L.
Urey, Marcus A.
Alexander, Kevin M. https://orcid.org/0000-0003-4024-3691
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 18 June 2025
First Online: 19 July 2025
Declarations
:
: Emily Margolin, MD, and Alessia Argiro, MD, have nothing to disclose. Lily Stern, MD, has received research grants from Intellia Therapeutics and Pfizer. Julie Rosenthal, MD, has received consulting fees from BridgeBio and Novo Nordisk, and research funding for clinical studies from Novo Nordisk, Ionis, and Alnylam. Marcus Urey, MD, has received consulting fees from Alnylam, AstraZeneca, BridgeBio, Pfizer, and research funding for clinical studies from Alexion, Intellia, and Ionis. Kevin Alexander, MD, has received consulting fees from Alexion, Alnylam, Arbor Biotechnologies, Bridgebio, Novo Nordisk, and Pfizer. Kevin Alexander, MD, is an Editorial Board member of Cardiology and Therapy. Kevin Alexander was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
